I migliori medici per il trattamento di Cancro ovarico - TOP-108 medici

Il Prof. Dr. Bülent Karagöz è specializzato in cancro ovarico con oltre 20 anni di esperienza in oncologia medica, incentrandosi sulla biologia dei tumori e sull'immunoterapia presso il Centro Medico Anadolu.

• Responsabile dell'Oncologia Medica presso il prestigioso Ospedale di Formazione GATA Haydarpaşa
• Autore di oltre 40 pubblicazioni nella ricerca sul cancro
• Professore presso la Facoltà di Medicina dell'Università Okan di Istanbul
• Membro dell'Associazione Turca di Oncologia Medica

La Dott.ssa Eda Tanrikulu è specializzata in oncologia medica e chemioterapia presso il Centro Medico Anadolu, con un focus sul cancro ovarico.

• Ha completato la formazione in oncologia medica presso l'Università di Marmara
• Ha guidato studi clinici internazionali in oncologia
• Fa parte di un team di revisione multidisciplinare per casi di cancro
• Ex capo dell'oncologia medica presso l'Haydarpaşa Numune Training and Research Hospital

Classificato al 1º posto nell'Esame di Competenza in Oncologia Medica della Turchia – il Dr. Keskin porta 28 anni di esperienza nel trattamento del cancro ovarico presso il Memorial Şişli Hospital.

• Eseguiti oltre 900 interventi oncologici tra cui chemioterapia e immunoterapia
• Premio per il Miglior Poster al 19º Congresso Nazionale del Cancro
• Membro di ASCO ed ESMO – segue gli standard internazionali di trattamento
• 42 pubblicazioni su riviste oncologiche internazionali

Oltre 900 procedure eseguite – Il Dott. Yalcinkaya è specializzato in oncologia ginecologica presso l'Anadolu Medical Center.

• 19 anni di esperienza in ginecologia e oncologia ginecologica
• Professore Associato con un focus sui casi di cancro ovarico
• Parte di un team oncologico multidisciplinare per un'assistenza completa
• Valutato 4,6 dai pazienti per la qualità dell'assistenza

Ha completato una fellowship presso l'Istituto Oncologico dell'Università di Hacettepe – La Dott.ssa Solak è specializzata nella diagnosi e nel trattamento del tumore ovarico.

• Ha ricevuto la formazione presso il Centro Oncologico MD Anderson dell'Università del Texas
• Si occupa di casi complessi di tumore ovarico
• Ha completato la residenza presso l'Ospedale di Formazione e Ricerca di Istanbul Sisli Etfal
• Membro della rete di ex alunni dell'Università di Hacettepe

Assoc. Prof. Gorkem Turkkan started his medical education at Gülhane Military Medical Academy in 2003 and completed it at Zonguldak Karaelmas (Bülent Ecevit) University Faculty of Medicine in 2009. He completed his specialization at Trakya University Faculty of Medicine, Department of Radiation Oncology and became a radiation oncology specialist in 2016.

After completing his compulsory service, he served as a Lecturer and Head of Department at Muğla Sıtkı Koçman University Faculty of Medicine, Department of Radiation Oncology, from May 2019 to February 2021. Meanwhile, between March and June 2020, he worked as a clinical researcher at Maastricht University Faculty of Medicine Department of Radiation Oncology – MAASTRO Clinic (Netherlands) on stereotactic radiotherapy, thoracic radiotherapy-related lung toxicity and proton therapy. While he was working at İstinye University Faculty of Medicine, Department of Radiation Oncology and Liv Hospital Ulus Radiation Oncology Clinic between March 2021 and April 2023, he received the title of Associate Professor in February 2023. She has been serving her patients at Hisar Hospital Intercontinental since May 2023.

He has performed both traditional radiotherapy and advanced radiotherapy throughout his career. He is one of the experienced physicians in our country in stereotactic radiotherapy and MRI-guided radiotherapy treatments, which have become increasingly popular and used especially recently. So far, he has successfully completed more than 2500 radiotherapy sessions with the MR-Linac device.

He has been a member of the Turkish Society of Radiation Oncology (TROD) since 2013 and the European Society of Radiotherapy and Oncology (ESTRO) since 2015. He has 27 articles published in domestic and international journals, 31 oral-poster presentations presented at national and international congresses, and 5 book chapters published by national and international publishing houses. He taught Term I and Term V undergraduate courses at Muğla Sıtkı Koçman University Faculty of Medicine, postgraduate courses within the scope of Ear Nose and Throat Department Specialization training, and Radiotherapy associate degree courses at İstinye University Vocational School of Health Services. She is currently working on 2 ongoing TÜBİTAK Projects. He is married and has a son.

MEDICAL INTERESTS

MR-Linac

Linac

Stereotactic (Pinpoint) Radiotherapy

Prostate Cancers

Breast Cancers

Lung Cancers

Rectum Cancers

Brain and Spinal Cord Cancers

Head and Neck Cancers

Volumetric Arc Therapy (VMAT)

Intensity Modulated Radiotherapy (IMRT)

Dr. Sertkaya graduated from Konya Meram Science High School in 2001 and entered Gazi University Medical Faculty the same year, graduating in 2008. He completed his urology specialization at Haydarpaşa Numune Training and Research Hospital in 2014, becoming a urology specialist.

Since becoming a specialist, he has focused on the sub-branch of Andrology, attending various training sessions and conferences and performing surgeries with some of the world's leading Andrology professors. In 2017, he passed the written and oral proficiency exams conducted by the European Association of Urology, earning the title of "FEBU."

In 2020, Dr. Sertkaya achieved the rank of Associate Professor of Urology. His journey in Urology and Andrology, which began in 2008, continues at the Andro Expertise Male Health and Aesthetics Center, which he founded in 2022. He sees patients in his own clinic and performs surgeries at affiliated hospitals.

Il Professor Cem Iyibozkurt è specializzato in chirurgia minimamente invasiva e robotica per il cancro ovarico presso l'Ospedale Florence Nightingale di Istanbul.

• Oltre 15 anni di esperienza in oncologia ginecologica
• Formazione in chirurgia robotica presso il Florida Hospital di Orlando
• Dottorato di ricerca in Medicina Molecolare presso l'Università di Istanbul
• Membro della Società Europea di Oncologia Ginecologica

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

Il Prof. Sadi Kerem Okutur è un professore associato con oltre 13 anni di esperienza in oncologia medica presso i principali ospedali in Turchia.

• Formazione presso l'Università di Istanbul e l'Università di Istanbul Bilim
• Membro della Società Europea di Oncologia Medica
• Ha pubblicato oltre 20 articoli e 10 capitoli di libri
• Vincitore del Premio per la Ricerca in Oncologia

Il Professor Dr. Mehmet Karaca è specializzato in tumori ginecologici con tecniche laparoscopiche avanzate presso il Complesso Ospedaliero Medical Park di Antalya.

• Oltre 20 anni di esperienza in ostetricia e ginecologia
• Formazione in chirurgia oncologica ginecologica dal Ministero della Salute
• Esperto in gravidanze ad alto rischio e uroginecologia
• Possiede un dottorato di ricerca in Ostetricia e Ginecologia

Specialista di spicco nel tumore ovarico con una profonda esperienza in sarcoma e oncologia ossea - Il Dr. Merimsky dirige la Clinica Oncologica Ambulatoriale presso il Sourasky Medical Center.

• Oltre 30 anni di esperienza in oncologia, specializzato in casi complessi
• Capo dell'Unità di Oncologia dei Tessuti Molli e delle Ossa
• Investigatore Senior presso il Weizmann Institute of Science e il Felsenstein Medical Research Center
• Membro della Facoltà ESMO per Sarcoma dei Tessuti Molli e delle Ossa
• Ha pubblicato ampiamente sulla ricerca e il trattamento del cancro

Doctor Brenda Pastrana is a mexican surgical Oncologist. 

Medical background.

Centro Medico Nacional 20 de Noviembre Issste, Surgical Oncologist in 2020.

Title by Universidad Autónoma de México UNAM.

Surgical Residency Instituto Mexicano del Seguro Social. 2015.

Title by Universidad de Quintana Roo. 

Board Certified by Conacem from 2020 to 2025 number 2171 

Board Certified by Conacem from 2025 to 2030 number 2171

Member of SMEO. Sociedad Mexicana de Oncología. 

University teacher at Universidad Anahuac of Medicine since 2020.

Dr. Axel Stang is a professor, Head Physician of Asklepios Barmbek Clinic, with a specialization in internal medicine, oncology, and hematology. He conducts antibody and molecular therapies to reduce tumor size, and is a member of multiple organizations and societies. Dr. Stang has published articles on the effectiveness of radiofrequency ablation in treating of metastatic colon cancer, and was a member of a research group that studied the effects of liver embolization. Patients can submit a request on the Bookimed website to get a consultation with the professor.

Responsabile del Gruppo di Oncologia Ginecologica Medica presso il San Raffaele – La Dott.ssa Mangili è specializzata in tumori ginecologici rari e nella preservazione della fertilità in oncologia.

• Oltre 20 anni alla guida dell'Unità di Oncologia Ginecologica presso il San Raffaele
• Membro del consiglio dei Multicenter Italian Trials in Ovarian Cancer
• Membro della Società Europea di Oncologia Ginecologica
• Professore in ostetricia e ginecologia dal 2017

Education and Specialization

• Faculty of Medicine, Hacettepe University
• 1999 - Akdeniz University, Faculty of Internal Medicine, Internal Medicine Specialization Training
• Internal Medicine Specialization Training in the USA, Akdeniz University (2013 - 2014)
• Internal Medicine Specialization Training in the USA (2013 - 2014) - Medical Oncology Department
• Akdeniz University, Faculty of Medicine, Department of Medical Oncology (Received Associate Professorship title)

Work Experience

• 2009 - Kayseri Training and Research Hospital, Hospital
• Acıbadem Kayseri
• 2017 - 2018 - Lara Private Anadolu Hospital
• 2018 - Medical Park Antalya Hospital Complex

Expertise

• Diagnosis of organ tumors
• Chemotherapy in cancer treatment
• Targeted cancer therapies
• Immunotherapy in cancer treatment
• Next-generation genetic research in cancer treatment
• Complementary medicine in cancer treatment
• Medical oncology

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations 

Prof. Montorsi is one of the top Italian experts in Urology and Andrology, with numerous scientific awards and 8,000+ urology/andrology surgeries. He directs the Urological Research Institute (URI) in Italy, is recognized among the most influential researchers of the past decade, and has developed his vein patching method to correct occlusive vein dysfunction. He is an Honorary Fellow of the Royal College of Surgeons of England and has written over 1,000 papers. He is a member of various medical organizations.